Foods
Cure8 research brief
Why This Matters
This preclinical study suggests a marine-derived collagen peptide fraction may strengthen intestinal barrier function, reduce oxidative stress, and partially restore gut microbiota in models of colitis — mechanisms relevant to ulcerative colitis and IBD.
If replicated and translated, such ingredients could inform future dietary strategies or supplements to support gut health.
Who Should Pay Attention
Researchers in microbiome and gut barrier biology; clinicians and patients interested in diet-based adjuncts for IBD (preclinical stage); translational scientists planning human studies.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This paper reports laboratory and mouse-model experiments testing a low-molecular-weight collagen peptide fraction (LSCP-I) derived from red fish (Lutjanus erythropterus) scales.
In cultured intestinal epithelial cells and in mice with DSS-induced colitis, the authors found that oral LSCP-I was associated with improvements in epithelial barrier measures, reduced oxidative stress markers, modulation of inflammatory cytokines, activation of the Nrf2 antioxidant pathway, and partial restoration of gut microbiota composition.
The study frames LSCP-I as a potential functional-food ingredient for prevention or management of IBD, but the evidence comes from preclinical models rather than human trials. Key details from the report: the peptide fraction is <3 kDa and was tested in Caco-2 cells and in a dextran-sulfate-sodium (DSS) mouse colitis model.
Reported effects include reduced reactive oxygen species, improved glutathione and SOD activity, lower intestinal permeability, and improved colon histology. This is early-stage, preclinical research.
It suggests biological plausibility for a food-derived peptide to support barrier function and redox balance, but it does not provide human safety or efficacy data. It also does not establish dosing, long-term effects, or formulation for human use.
Keep In Mind
Results come from cultured cells and a DSS mouse model, not from human trials. Effects, doses, and safety in people are unknown. The study identifies mechanisms (Nrf2 activation, antioxidant effects, microbiota shifts) that merit further research.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFoods
PublisherMDPI AG
AuthorsQi Deng, Muhammad Kashif Imtiaz, Jiabao Huang +4 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 13, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: Department of Education of Guangdong Province, award 2025ZDZX4018; award 2025ZDZX4018
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
UMN researchers explore how diet impacts gut microbiome
This research looks at whether donor and patient diets can influence how well fecal microbiota transplants work. For people with IBD (including Crohn’s and ulcerative colitis), improving FMT success could mean better...
Rise in IBD cases among youngsters; doctors suggest to eat homemade food
The article highlights a reported rise in IBD among young people and reinforces that diet and lifestyle factors may influence risk and flare-ups. It reminds readers that IBD symptoms can be mistaken for common...
5 Best Foods to Eat After a Crohn’s or Ulcerative Colitis Flare
After a Crohn’s or UC flare you may tolerate less fiber and need easy-to-digest foods and extra protein to support recovery. This article gives practical, food-based suggestions to help with nutrient intake while your...